QA: Dermata Therapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001853816_2024_Dermata_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001853816, Dermata Therapeutics Inc

  xvar xval
0 AssetsCurrent 0
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 7,978,634
4 LiabilitiesCurrent 866,028
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 757,588
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,972,140
9 ResearchAndDevelopmentExpense 4,069,766
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 247,216
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 7,978,634
1 Liabilities 1,623,616
2 Expenses 8,041,906
3 Revenues 0
4 StockholdersEquity 6,355,018
5 NetIncome -7,794,690
6 ComprehensiveNetIncome -7,794,690
7 BaseVar 8,945,686
8 EconomicCapitalRatiobeforeLimitedLiability 1.26
9 EconomicCapitalRatio 2.50

Edgar->Model Mapping

Feature Distribution

Change over Time